Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of
Sports and Exercise Medicine ISSN: 2469-5718

Citation

FERNANDEZ L, SEIJAS R, PÉREZ-BELLMUNT A, RAGAZZI P, PEILLON O, et al. (2019) Anterior Cruciate Ligament Reconstruction with Platelet Rich Plasma: Systematic Review. Int J Sports Exerc Med 5:142. doi.org/10.23937/2469-5718/1510142

Copyright

© 2019 FERNANDEZ L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

RESEARCH ARTICLE | OPEN ACCESS DOI: 10.23937/2469-5718/1510142

Anterior Cruciate Ligament Reconstruction with Platelet Rich Plasma: Systematic Review

Laura FERNANDEZ1, Roberto SEIJAS1-3, Albert PÉREZ-BELLMUNT1*, Paolo RAGAZZI1, Olivier PEILLON1 and Pedro ALVAREZ1-4

1Anatomy Unit, International University of Catalonia, Spain

2Fundación García-Cugat, Spain

3GC Arthroscopy, Chiron Hospital, Spain

4Catalan Mutualidad de Futbolistas, Spanish Football Federation, Spain

Abstract

Objective

The aim of this study was reviewed the scientific evidence of the relationship that could exist between the use of Platelet Rich Plasma (PRP) after the reconstruction of the Anterior Cruciate Ligament (ACL).

Design

We performed a systematic using the following key words: platelet rich plasma AND anterior cruciate ligament. Abstracts were screened by a single reviewer. For those studies meeting the eligibility criteria, full-text articles were obtained.

Results

From 127 studies found only 5 articles were included in this systematic review. We found the presence of inflammatory diseases, DM, advanced osteoarthrosis (grade III-IV), previous knee surgeries, malignant diseases, contrast allergy, renal disease and thrombocytopenia.

Conclusion

The use of the platelet rich plasma after the ACL reconstruction with patellar tendon, demonstrates a better autograft recovery in terms of vascularization, bone remodeling and edema decreasing, achieving an earlier autograft homogenization.